Suppr超能文献

经导管溶栓治疗下腔静脉滤器有症状的血栓阻塞

Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter.

作者信息

Xiao Liang, Shen Jing, Tong Jia-Jie, Zhang Zhe, Mu Xiao-Lin, Yi Zheng-Jia, Bai Shuo, Xu Ke

机构信息

Department of Radiology, The First Hospital of China Medical University, Liaoning, Shenyang 110001;

出版信息

Exp Ther Med. 2013 Feb;5(2):533-538. doi: 10.3892/etm.2012.843. Epub 2012 Nov 30.

Abstract

Thrombus within an inferior vena cava (IVC) filter reduces filter patency and venous return from the lower extremities, and may progress to complete IVC occlusion. The clinical experiences and outcomes of transcatheter thrombolytic therapy for symptomatic IVC thrombosis following filter implantation have not been widely reported. The aim of the current study was to evaluate the efficiency and safety of trans-catheter thrombolysis for the treatment of symptomatic IVC thrombosis in patients with implanted IVC filters. Transcatheter thrombolysis was used to treat 5 patients with thrombosis of the filter-bearing IVC causing symptoms in 10 limbs from October 2005 to September 2010. The patients were implanted with a second IVC filter through the right internal jugular vein, followed by recanalization of the occluded IVC and intravenous transcatheter thrombolysis. The IVC filters were retrieved through the femoral or right internal jugular vein after the thrombus had dissolved. Technical and clinical outcome, complications and postoperative pulmonary embolism were monitored. A total of 5 filters were implanted and 6 filters were retrieved later. Technically and clinically successful recanalization and thrombolysis were achieved in 5 of 5 patients and 10 of 10 symptomatic limbs. The median thrombolysis period was 13 days (range, 8-14 days). The median dwell time for the filters that were removed was 50.5 days (range, 14-73 days). No major bleeding occurred during the current study. During clinical follow-up, no clinically detectable pulmonary embolism was observed. Endovascular recanalization and transcatheter thrombolysis of IVC thrombosis are efficient, feasible and safe in the presence of an IVC filter.

摘要

下腔静脉(IVC)滤器内的血栓会降低滤器通畅性以及下肢的静脉回流,并且可能进展为下腔静脉完全闭塞。滤器植入后,针对有症状的下腔静脉血栓形成进行经导管溶栓治疗的临床经验和结果尚未得到广泛报道。本研究的目的是评估经导管溶栓治疗植入IVC滤器患者有症状的下腔静脉血栓形成的有效性和安全性。2005年10月至2010年9月,采用经导管溶栓治疗5例因带滤器的下腔静脉血栓形成导致10条肢体出现症状的患者。通过右颈内静脉为患者植入第二个IVC滤器,随后对闭塞的下腔静脉进行再通并进行静脉内导管溶栓。血栓溶解后,通过股静脉或右颈内静脉取出IVC滤器。监测技术和临床结果、并发症及术后肺栓塞情况。共植入5个滤器,之后取出6个滤器。5例患者中的5例以及10条有症状肢体中的10条在技术和临床上实现了成功再通和溶栓。溶栓中位时间为13天(范围8 - 14天)。取出滤器的中位留置时间为50.5天(范围14 - 73天)。在本研究期间未发生大出血。在临床随访期间,未观察到临床可检测到的肺栓塞。在存在IVC滤器的情况下,下腔静脉血栓形成的血管腔内再通和经导管溶栓是有效、可行且安全的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c1/3570124/84536e5564c5/ETM-05-02-0533-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验